OIRA Conclusion of EO 12866 Regulatory Review
RIN: 0910-AI76 View EO 12866 Meetings | Received Date: 12/10/2024 |
Title: Tobacco Product Standard for Nicotine Level of Certain Tobacco Products | |
Agency/Subagency: HHS / FDA | Stage: Proposed Rule |
Concluded Action: Consistent with Change | Concluded Date: 01/03/2025 |
Section 3(f)(1) Significant *: Yes | |
Legal Deadline: None | Economically Significant **: No |
Publication Date: | Unfunded Mandates: Private Sector |
Major: Yes | Related To Homeland Security: No |
Regulatory Flexibility Analysis Required: Yes | Small Entities Affected: Businesses |
Federalism Implications: Yes | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
International Impacts: No | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
Pandemic Response: No | |
|